Alterity Therapeutics (PRNAD) Other Non-Current Assets (2009 - 2016)

Alterity Therapeutics (PRNAD) has reported Other Non-Current Assets for 7 consecutive years, with $32998.0 the latest figure, recorded in Q4 2016.

• In Q4 2016, Other Non-Current Assets rose 0.85% year-over-year to $32998.0; the TTM figure through Dec 2016 stood at $32998.0 (up 0.85% YoY), while the FY2016 annual figure was $32998.0, changed N/A from the prior year.
• Other Non-Current Assets came in at $32998.0 for Q4 2016 at Alterity Therapeutics, roughly flat from $32845.9 in the prior quarter.
• The five-year high for Other Non-Current Assets was $43699.5 in Q2 2013, with the low at $32718.6 in Q4 2015.
• Average Other Non-Current Assets over 4 years is $36446.7, with a median of $35343.2 recorded in 2015.
• Across the five-year window, Other Non-Current Assets increased 14.29% in 2013 and decreased 7.07% in 2016, its largest moves.
• Year by year, Other Non-Current Assets stood at $39286.3 in 2012, then rose by 11.23% to $43699.5 in 2013, then dropped by 25.13% to $32718.6 in 2015, then rose by 0.85% to $32998.0 in 2016.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $32998.0, $32845.9, and $32718.6 for Q4 2016, Q2 2016, and Q4 2015 respectively.